By Reuters Staff June 09, 2022 NEW YORK (Reuters Health) – An experimental hydrogel injected into spinal discs appears to relieve pain and improve function in patients with chronic low-back pain caused by degenerative disc disease (DDD), according to an early feasibility study. The hydrogel was successfully and safely injected into all targeted intervertebral discs and led...